You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
哈藥股份(600664.SH)半年度預盈2.91億-3.49億元 同比扭虧為盈
格隆匯 07-16 17:58

格隆匯7月16日丨哈藥股份(600664.SH)公佈,預計2021年上半年度實現歸屬於上市公司股東的淨利潤與上年同期相比,將扭虧為盈,實現歸屬於上市公司股東的淨利潤29118萬元到34942萬元;歸屬於上市公司股東扣除非經常性損益後的淨利潤17258元到20710萬元左右。業績預盈的主要原因如下:

1報吿期內公司聚焦目標管理,通過細分業務團隊及相關治療領域,不斷提升團隊專業化能力,公司工業部分同比銷量增長82.2%實現了銷售收入的大幅增長;品種結構較同期明顯改善,毛利水平較同期增長13%2021年上半年盈利水平較同期大幅提升。

2、報吿期內,公司持續優化和完善選人用人機制及績效管理體系,三項制度改革平穩有序完成為公司市場化經營機制轉型和持續穩定發展提供了保障

3報吿期內,公司繼續加強精細化管理,管理效率產能利用均得到提高,導致公司成本費用進一步降低,利潤同比增加

4報吿期內,公司非經常性損益增加系下屬分公司處置閒置資產獲得徵收補償款10039萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account